United States · Bill · S
S. 1165 (102nd)
A bill to extend the patent term of certain products.
Introduced
23 May 1991
Last action
—
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process: (1) the patentee filed a new drug application in 1982; (2) the patentee awaited approval by the Food and Drug Administration for at least 78 months; and (3) such new drug application was approved in 1988. Prescribes a formula for patent term extension, and sets forth administrative notification procedures.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
4 official files
Reported to Senate (text)
Reported to Senate (text)
Reported to Senate · EN
Introduced in Senate (text)
Introduced in Senate · EN
Reported to Senate with amendment(s)
summary · EN · 22 September 1992
Introduced in Senate
summary · EN · 23 May 1991
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/102nd-congress/senate-bill/1165
- Open data entity: https://api.congress.gov/v3/bill/102/s/1165